|
JPH0329734A
(ja)
|
1989-06-20 |
1991-02-07 |
Kubota Corp |
ラベルプリンタ
|
|
US7144731B2
(en)
|
1989-10-16 |
2006-12-05 |
Amgen Inc. |
SCF antibody compositions and methods of using the same
|
|
US20050276784A1
(en)
|
1990-08-27 |
2005-12-15 |
Solan-Kettering Institute For Cancer Research |
Ligand for the c-kit receptor and methods of use thereof
|
|
DE4205148A1
(de)
|
1991-05-25 |
1993-01-21 |
Boehringer Mannheim Gmbh |
Monoklonale antikoerper gegen c-kit
|
|
WO1994008039A1
(en)
|
1992-10-02 |
1994-04-14 |
Systemix, Inc. |
Method of enrichment for human hematopoietic stem cells using c-kit
|
|
US5821108A
(en)
|
1995-04-07 |
1998-10-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enrichment for a thymocyte subset having progenitor cell activity using c-kit as a selection marker
|
|
CN1173776C
(zh)
|
1996-06-28 |
2004-11-03 |
卡钳技术有限公司 |
在微规模流体性设备里的高通过量的筛选分析系统
|
|
WO1999019500A1
(en)
|
1997-10-10 |
1999-04-22 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Healt H And Human Services |
Complex of biotinylated viral vector and ligand for targeted gene delivery
|
|
AU4323599A
(en)
|
1998-05-29 |
1999-12-13 |
Instituto Superiore Di Sanita |
Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
|
|
EP1103814B1
(en)
|
1998-07-31 |
2005-12-21 |
Mitsubishi Chemical Corporation |
Method for assaying physiologically active component
|
|
US6989248B2
(en)
|
1999-05-06 |
2006-01-24 |
The Trustees Of Columbia University In The City Of New York |
Methods of use of compounds which inhibit the stem cell signaling pathway
|
|
JP2003514564A
(ja)
|
1999-11-24 |
2003-04-22 |
エムシーエス マイクロ キャリア システムズ ゲーエムベーハー |
核局在化シグナルまたはタンパク質導入領域の多量体を含むポリペプチド、および分子を細胞内へ移入するためのその使用法
|
|
US20030082155A1
(en)
|
1999-12-06 |
2003-05-01 |
Habener Joel F. |
Stem cells of the islets of langerhans and their use in treating diabetes mellitus
|
|
US7862810B2
(en)
|
2000-07-31 |
2011-01-04 |
New York Medical College |
Methods and compositions for the repair and/or regeneration of damaged myocardium
|
|
US20040003420A1
(en)
|
2000-11-10 |
2004-01-01 |
Ralf Kuhn |
Modified recombinase
|
|
US20050222030A1
(en)
|
2001-02-21 |
2005-10-06 |
Anthony Allison |
Modified annexin proteins and methods for preventing thrombosis
|
|
CA2439472A1
(en)
|
2001-02-27 |
2002-09-06 |
University Of Rochester |
Methods and compositions for modifying apolipoprotein b mrna editing
|
|
CN100516204C
(zh)
|
2001-04-24 |
2009-07-22 |
味之素株式会社 |
干细胞及其分离方法
|
|
AU2002330714A1
(en)
|
2001-05-30 |
2003-01-02 |
Biomedical Center |
In silico screening for phenotype-associated expressed sequences
|
|
EP2277991A1
(en)
|
2001-08-21 |
2011-01-26 |
Ventana Medical Systems, Inc. |
Method and quantification assay for determining c-kit/SCF/pAKT status
|
|
US8021876B2
(en)
|
2001-11-15 |
2011-09-20 |
Children's Medical Center Corporation |
Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
|
|
CN100455275C
(zh)
|
2002-02-06 |
2009-01-28 |
祥丰医疗有限公司 |
包覆有可促进内皮细胞的黏附和分化的包衣的医疗装置
|
|
US20040161419A1
(en)
|
2002-04-19 |
2004-08-19 |
Strom Stephen C. |
Placental stem cells and uses thereof
|
|
AU2003241313A1
(en)
|
2002-04-23 |
2003-11-10 |
Roger Williams Hospital |
Compositions and methods for stem cell delivery
|
|
US20040005623A1
(en)
|
2002-06-10 |
2004-01-08 |
Longley B. Jack |
Method of determining tumor sensitivities to therapeutic drugs
|
|
AU2003245752A1
(en)
|
2002-06-28 |
2004-01-19 |
Bio Transplant, Inc. |
Process for promoting graft acceptance by depletion of hematopoietic stem cells
|
|
WO2004005531A2
(en)
|
2002-07-05 |
2004-01-15 |
Roger Williams Medical Center |
Targeting and tracking of cells to specific organs and tissues in vivo
|
|
US20050032122A1
(en)
|
2003-08-06 |
2005-02-10 |
Shiaw-Min Hwang |
Optimizing culture medium for CD34<+> hematopoietic cell expansion
|
|
US20050124896A1
(en)
|
2003-08-25 |
2005-06-09 |
Jacob Richter |
Method for protecting implantable sensors and protected implantable sensors
|
|
EA200600495A1
(ru)
|
2003-09-23 |
2006-10-27 |
Новартис Аг |
Комбинация ингибитора vegf рецептора с химиотерапевтическим агентом
|
|
TWI338714B
(en)
|
2003-12-02 |
2011-03-11 |
Cathay General Hospital |
Method of isolation and enrichment of mesenchymal stem cells from amniotic fluid
|
|
EP1718735A1
(en)
|
2004-02-11 |
2006-11-08 |
Aldagen, Inc. |
Stem cell populations and methods of use
|
|
US20050187607A1
(en)
|
2004-02-20 |
2005-08-25 |
Akhtar Adil J. |
Drug delivery device
|
|
USRE46379E1
(en)
|
2004-04-08 |
2017-04-25 |
Cornell Research Foundation, Inc. |
Functional immunohistochemical cell cycle analysis as a prognostic indicator for cancer
|
|
WO2006031524A2
(en)
|
2004-09-10 |
2006-03-23 |
The Regents Of The Unversity Of Colorado |
Early detection of hemangiosarcoma and angiosarcoma
|
|
WO2006062946A2
(en)
|
2004-12-06 |
2006-06-15 |
University Of Florida Research Foundation, Inc. |
Incorporation of bone marrow derived stem cells in tumors
|
|
CA2593549C
(en)
|
2005-01-07 |
2016-04-26 |
Wake Forest University Health Sciences |
Regeneration of pancreatic islets by amniotic fluid stem cell therapy
|
|
WO2006089048A2
(en)
|
2005-02-16 |
2006-08-24 |
Hemogenix, Inc. |
Methods of screening compounds to predict toxicity and residual proliferative and differentiation capacity of the lympho-hematopoietic system
|
|
US20060222634A1
(en)
|
2005-03-31 |
2006-10-05 |
Clarke Diana L |
Amnion-derived cell compositions, methods of making and uses thereof
|
|
CA2606081C
(en)
|
2005-04-26 |
2013-09-17 |
Markus M. Heiss |
Combination of the application of antibodies for immunostimulation together with glucocorticoids
|
|
US20070041948A1
(en)
|
2005-07-20 |
2007-02-22 |
Seoul National University Industry Foundation |
Method for culturing and proliferating hematopoietic stem cells and progenitor cells using human endometrial cells
|
|
US20080274469A1
(en)
|
2005-10-21 |
2008-11-06 |
The Regents Of The University Of California |
C-Kit Oncogene Mutations in Melanoma
|
|
KR101353763B1
(ko)
|
2005-11-07 |
2014-01-21 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
혈관 신생 저해 물질과 ｃ―ｋｉｔ 키나아제 저해 물질의병용
|
|
US20090304625A1
(en)
|
2006-01-18 |
2009-12-10 |
Ahsan Husain |
Modulators of cardiac cell hypertrophy and hyperplasia
|
|
US20070254319A1
(en)
|
2006-04-07 |
2007-11-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Identification of a constitutively resistant cancer stem cell
|
|
TWI395754B
(zh)
|
2006-04-24 |
2013-05-11 |
Amgen Inc |
人類化之ｃ-ｋｉｔ抗體
|
|
US8568286B2
(en)
|
2006-06-14 |
2013-10-29 |
Cardiac Pacemakers, Inc. |
Methods to position therapeutic agents using a magnetic field
|
|
EP3255061B1
(en)
|
2006-11-03 |
2021-06-16 |
The Board of Trustees of the Leland Stanford Junior University |
Selective immunodepletion of endogenous stem cell niche for engraftment
|
|
WO2008115300A1
(en)
|
2006-12-01 |
2008-09-25 |
Apocell, Inc. |
C-kit phosphorylation in cancer
|
|
WO2008076143A1
(en)
|
2006-12-18 |
2008-06-26 |
Osi Pharmaceuticals, Inc. |
Combination of igfr inhibitor and anti-cancer agent
|
|
WO2008085951A2
(en)
|
2007-01-04 |
2008-07-17 |
Vivek Mittal |
Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells
|
|
DE102007008650B4
(de)
|
2007-02-20 |
2012-06-06 |
Charité - Universitätsmedizin Berlin |
Zellen zur Therapie des Herzens
|
|
JP2010530214A
(ja)
|
2007-03-01 |
2010-09-09 |
クライオ−セル インターナショナル インコーポレイテッド |
子宮内膜細胞／月経血細胞の獲得、単離および凍結保存
|
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
|
WO2009058983A2
(en)
|
2007-10-30 |
2009-05-07 |
University Of Louisville Research Foundation, Inc. |
Subpopulations of bone marrow-derived adherent stem cells and methods of use therefor
|
|
US20090169613A1
(en)
|
2007-11-09 |
2009-07-02 |
Reznik Boris N |
Targeting of tumor stem cells through selective silencing of boris expression
|
|
US20110262465A1
(en)
|
2008-10-22 |
2011-10-27 |
Genentech, Inc. |
Prostate stem cells and uses thereof
|
|
JP5923035B2
(ja)
|
2009-03-24 |
2016-05-24 |
バイオセプト インコーポレイティッド |
細胞の捕捉および解析のデバイスおよび方法
|
|
WO2010136508A2
(en)
|
2009-05-28 |
2010-12-02 |
Glaxo Group Limited |
Stem cell targeting
|
|
EP2259065A1
(en)
|
2009-06-03 |
2010-12-08 |
Erasmus University Medical Center Rotterdam |
Methods, reagents and kits for flow cytometric immunophenotyping
|
|
WO2013166281A1
(en)
|
2012-05-02 |
2013-11-07 |
Cedars-Sinai Medical Center |
Bi-functional compositions for targeting cells to diseased tissues and methods of using same
|
|
US20110104787A1
(en)
|
2009-11-05 |
2011-05-05 |
President And Fellows Of Harvard College |
Fusion Peptides That Bind to and Modify Target Nucleic Acid Sequences
|
|
US9149544B2
(en)
|
2009-11-06 |
2015-10-06 |
The Penn State Research Foundation |
Bioconjugation of calcium phosphosilicate nanoparticles for selective targeting of cells in vivo
|
|
US8518716B2
(en)
|
2009-11-30 |
2013-08-27 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Soluble CD117 (sc-kit) for diagnosis of preeclampsia and eclampsia
|
|
WO2011073521A1
(en)
|
2009-12-15 |
2011-06-23 |
Petri Salven |
Methods for enriching adult-derived endothelial progenitor cells and uses thereof
|
|
US20130011380A1
(en)
|
2009-12-18 |
2013-01-10 |
Blau Helen M |
Use of Cytidine Deaminase-Related Agents to Promote Demethylation and Cell Reprogramming
|
|
RU2558931C2
(ru)
|
2010-01-12 |
2015-08-10 |
Нестек С.А. |
Способы предсказания ответа трижды негативного рака молочной железы на терапию
|
|
WO2012004778A1
(en)
|
2010-07-09 |
2012-01-12 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Method for in-vitro monitoring of neuronal disorders and use thereof
|
|
WO2012047951A2
(en)
|
2010-10-05 |
2012-04-12 |
The Brigham And Women's Hospital, Inc. |
Human lung stem cells and uses thereof
|
|
EP2640827B1
(en)
|
2010-11-16 |
2023-07-19 |
Ingeneron, Inc. |
Methods for preserving target cells
|
|
WO2012068243A2
(en)
|
2010-11-16 |
2012-05-24 |
Ingeneron, Inc. |
Methods for obtaining target cells
|
|
US9816998B2
(en)
|
2011-04-01 |
2017-11-14 |
Cornell University |
Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers
|
|
WO2012142411A1
(en)
|
2011-04-15 |
2012-10-18 |
Clavis Pharma Asa |
Systems and methods for detecting hent1 expression in hematological disorders
|
|
CN103841848B
(zh)
|
2011-05-11 |
2017-12-05 |
施特姆拉德有限公司 |
辐射防护装置及其方法
|
|
AR086044A1
(es)
|
2011-05-12 |
2013-11-13 |
Imclone Llc |
Anticuerpos que se unen especificamente a un dominio extracelular de c-kit y usos de los mismos
|
|
WO2012171112A1
(en)
|
2011-06-14 |
2012-12-20 |
Mcmaster University |
Isolated embryonic stem cells that express lineage markers and associated methods
|
|
CN102876666B
(zh)
|
2011-07-15 |
2015-02-04 |
内蒙古弘泰医学科技有限公司 |
Rna胞体及其用途
|
|
CN103088008B
(zh)
|
2011-10-31 |
2014-08-20 |
中国科学院微生物研究所 |
胞苷脱氨酶及其编码基因和它们的应用
|
|
EP2836226B1
(en)
|
2012-02-24 |
2017-06-28 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for the treatment of hemoglobinopathies
|
|
KR101384360B1
(ko)
|
2012-05-04 |
2014-04-14 |
아주대학교산학협력단 |
Ｓｃｆ 또는 이의 수용체를 억제하는 물질을 포함하는 혈관 투과성 관련 질환의 치료 또는 예방용 조성물
|
|
ES2728782T3
(es)
|
2012-05-25 |
2019-10-28 |
Univ California |
Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
|
|
WO2013188037A2
(en)
|
2012-06-11 |
2013-12-19 |
Agilent Technologies, Inc |
Method of adaptor-dimer subtraction using a crispr cas6 protein
|
|
AU2013274965B2
(en)
|
2012-06-14 |
2018-07-19 |
Erasmus University Medical Center Rotterdam |
Methods, reagents and kits for detecting minimal residual disease
|
|
PT2877490T
(pt)
|
2012-06-27 |
2019-02-12 |
Univ Princeton |
Inteínas clivadas, conjugados e suas utilizações
|
|
EP2890780B8
(en)
|
2012-08-29 |
2020-08-19 |
Sangamo Therapeutics, Inc. |
Methods and compositions for treatment of a genetic condition
|
|
EP2895170A4
(en)
|
2012-09-14 |
2016-07-20 |
Childrens Medical Center |
INHIBITION OF VIRAL INFECTION-RELATED ASTHMA WITH A C-KIT HEMMER
|
|
WO2014043131A1
(en)
|
2012-09-14 |
2014-03-20 |
The Regents Of The University Of California |
Lentiviral vector for stem cell gene therapy of sickle cell disease
|
|
CA2886607A1
(en)
|
2012-10-17 |
2014-04-24 |
Cedars-Sinai Medical Center |
Molecular signatures of ovarian cancer
|
|
US20150299315A1
(en)
|
2012-10-22 |
2015-10-22 |
Becton, Dickinson And Company |
Non-b-lineage cells capable of producing antibody
|
|
EP2914273B1
(en)
|
2012-10-26 |
2018-07-04 |
Cedars-Sinai Medical Center |
Therapeutic cells depleted of specific subpopulations of cells for use in tissue repair of regeneration
|
|
WO2014081712A2
(en)
|
2012-11-20 |
2014-05-30 |
Celgene Avilomics Research, Inc. |
Methods of treating a disease or disorder associated with bruton's tyrosine kinase
|
|
DK3363902T3
(da)
|
2012-12-06 |
2020-01-02 |
Sigma Aldrich Co Llc |
Crispr-baseret genommodifikation og -regulering
|
|
PT2931898E
(pt)
|
2012-12-12 |
2016-06-16 |
Harvard College |
Manipulação e otimização de sistemas, métodos e composições para manipulação de sequências com domínios funcionais
|
|
SG10201707569YA
(en)
|
2012-12-12 |
2017-10-30 |
Broad Inst Inc |
Delivery, Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation and Therapeutic Applications
|
|
IL308158A
(en)
|
2012-12-17 |
2023-12-01 |
Harvard College |
Rna-guided human genome engineering
|
|
US20210137991A1
(en)
|
2013-02-08 |
2021-05-13 |
Themba Inc. |
Gene editing for autoimmune disorders
|
|
US20160145348A1
(en)
|
2013-03-14 |
2016-05-26 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to modify cells for therapeutic objectives
|
|
US9234213B2
(en)
|
2013-03-15 |
2016-01-12 |
System Biosciences, Llc |
Compositions and methods directed to CRISPR/Cas genomic engineering systems
|
|
US20140273230A1
(en)
|
2013-03-15 |
2014-09-18 |
Sigma-Aldrich Co., Llc |
Crispr-based genome modification and regulation
|
|
CN105408483A
(zh)
|
2013-03-15 |
2016-03-16 |
通用医疗公司 |
遗传和表观遗传调节蛋白至特定基因组基因座的rna引导的靶向
|
|
WO2014141306A2
(en)
|
2013-03-15 |
2014-09-18 |
Rajiv Gandhi Centre For Biotechnology |
Methods and materials for identifying therapeutic response in chronic myeloid leukemia
|
|
WO2014186686A2
(en)
|
2013-05-17 |
2014-11-20 |
Two Blades Foundation |
Targeted mutagenesis and genome engineering in plants using rna-guided cas nucleases
|
|
EP3603679B1
(en)
|
2013-06-04 |
2022-08-10 |
President and Fellows of Harvard College |
Rna-guided transcriptional regulation
|
|
WO2014197748A2
(en)
*
|
2013-06-05 |
2014-12-11 |
Duke University |
Rna-guided gene editing and gene regulation
|
|
WO2014197821A1
(en)
|
2013-06-06 |
2014-12-11 |
President And Fellows Of Harvard College |
Homeodomain fusion proteins and uses thereof
|
|
JP2016528890A
(ja)
|
2013-07-09 |
2016-09-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ＣＲＩＳＰＲ／Ｃａｓ系を用いるゲノム編集の治療用の使用
|
|
FR3008408B1
(fr)
|
2013-07-11 |
2018-03-09 |
Mc Saf |
Nouveaux conjugues anticorps-medicament et leur utilisation en therapie
|
|
PL3019619T3
(pl)
|
2013-07-11 |
2022-01-10 |
Modernatx, Inc. |
Kompozycje zawierające syntetyczne polinkleotydy kodujące białka powiązane z crispr i syntetyczne sgrna oraz sposoby ich stosowania
|
|
US20150044772A1
(en)
|
2013-08-09 |
2015-02-12 |
Sage Labs, Inc. |
Crispr/cas system-based novel fusion protein and its applications in genome editing
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
|
CN111218447B
(zh)
|
2013-11-07 |
2024-10-11 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
EP3835419A1
(en)
|
2013-12-12 |
2021-06-16 |
The Regents of The University of California |
Methods and compositions for modifying a single stranded target nucleic acid
|
|
CN111206032B
(zh)
|
2013-12-12 |
2024-07-19 |
布罗德研究所有限公司 |
用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用
|
|
US20150166984A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting alpha-antitrypsin point mutations
|
|
JP6793547B2
(ja)
|
2013-12-12 |
2020-12-02 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
最適化機能ＣＲＩＳＰＲ−Ｃａｓ系による配列操作のための系、方法および組成物
|
|
WO2015148512A1
(en)
|
2014-03-24 |
2015-10-01 |
Qt Holdings Corp |
Shaped articles including hydrogels and methods of manufacture and use thereof
|
|
US10369104B2
(en)
|
2014-04-01 |
2019-08-06 |
Children's Hospital Los Angeles |
Targeted polymerized nanoparticles for cancer treatment
|
|
WO2015191693A2
(en)
|
2014-06-10 |
2015-12-17 |
Massachusetts Institute Of Technology |
Method for gene editing
|
|
ES2945588T3
(es)
|
2014-08-26 |
2023-07-04 |
Univ Leland Stanford Junior |
Injerto de células madre con una combinación de un agente dirigido a las células madre y modulación de señalización inmunoreguladora
|
|
US10450584B2
(en)
|
2014-08-28 |
2019-10-22 |
North Carolina State University |
Cas9 proteins and guiding features for DNA targeting and genome editing
|
|
EP2995948A1
(en)
|
2014-09-09 |
2016-03-16 |
Ecole Polytechnique Federale de Lausanne (EPFL) |
Methods and compounds useful in hematopoietic stem cell medicine
|
|
WO2016049258A2
(en)
|
2014-09-25 |
2016-03-31 |
The Broad Institute Inc. |
Functional screening with optimized functional crispr-cas systems
|
|
AU2015332533B2
(en)
|
2014-10-14 |
2018-08-30 |
Halozyme, Inc. |
Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same
|
|
EP3212221B1
(en)
|
2014-10-29 |
2023-12-06 |
Massachusetts Eye & Ear Infirmary |
Efficient delivery of therapeutic molecules in vitro and in vivo
|
|
JP6153180B2
(ja)
|
2014-11-04 |
2017-06-28 |
国立大学法人神戸大学 |
脱塩基反応により標的化したｄｎａ配列に特異的に変異を導入する、ゲノム配列の改変方法、並びにそれに用いる分子複合体
|
|
WO2016083777A1
(en)
|
2014-11-26 |
2016-06-02 |
Isis Innovation Limited |
Detection of acute myeloid leukaemia (aml) leukaemic stem cells (lsc)
|
|
EP3230452B1
(en)
|
2014-12-12 |
2025-06-11 |
The Broad Institute, Inc. |
Dead guides for crispr transcription factors
|
|
AU2015367378A1
(en)
|
2014-12-17 |
2017-06-15 |
Proqr Therapeutics Ii B.V. |
Targeted RNA editing
|
|
US12129471B2
(en)
|
2015-02-23 |
2024-10-29 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of human genetic diseases including hemoglobinopathies
|
|
WO2016135558A2
(en)
|
2015-02-23 |
2016-09-01 |
Crispr Therapeutics Ag |
Materials and methods for treatment of hemoglobinopathies
|
|
AU2016226077B2
(en)
|
2015-03-03 |
2021-12-23 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases with altered PAM specificity
|
|
AU2016232719A1
(en)
|
2015-03-18 |
2017-10-12 |
Memorial Sloan Kettering Cancer Center |
Compositions and methods for targeting CD99 in haematopoietic and lymphoid malignancies
|
|
HK1256681A1
(zh)
|
2015-04-06 |
2019-10-04 |
President And Fellows Of Harvard College |
用於非清髓性预处理的组合物和方法
|
|
CA2985615A1
(en)
|
2015-05-11 |
2016-11-17 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating hiv infection and aids
|
|
CN106011104B
(zh)
|
2015-05-21 |
2019-09-27 |
清华大学 |
利用拆分Cas系统进行基因编辑和表达调控方法
|
|
US9957501B2
(en)
|
2015-06-18 |
2018-05-01 |
Sangamo Therapeutics, Inc. |
Nuclease-mediated regulation of gene expression
|
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
|
WO2016205759A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
|
|
EP3957731A1
(en)
|
2015-07-15 |
2022-02-23 |
Rutgers, The State University of New Jersey |
Nuclease-independent targeted gene editing platform and uses thereof
|
|
US9512446B1
(en)
|
2015-08-28 |
2016-12-06 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
US11008555B2
(en)
|
2015-09-17 |
2021-05-18 |
The Regents Of The University Of California |
Variant Cas9 polypeptides comprising internal insertions
|
|
WO2017059241A1
(en)
|
2015-10-02 |
2017-04-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Lentiviral protein delivery system for rna-guided genome editing
|
|
WO2017070632A2
(en)
|
2015-10-23 |
2017-04-27 |
President And Fellows Of Harvard College |
Nucleobase editors and uses thereof
|
|
EP3371306B8
(en)
|
2015-11-04 |
2023-02-22 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of hemoglobinopathies
|
|
US11866727B2
(en)
|
2015-11-06 |
2024-01-09 |
Crispr Therapeutics Ag |
Materials and methods for treatment of glycogen storage disease type 1A
|
|
WO2017093804A2
(en)
|
2015-12-01 |
2017-06-08 |
Crispr Therapeutics Ag |
Materials and methods for treatment of alpha-1 antitrypsin deficiency
|
|
IL313038A
(en)
|
2016-03-14 |
2024-07-01 |
Editas Medicine Inc |
Crispr/cas-related methods and compositions for treating beta hemoglobinopathies
|
|
EP3433364A1
(en)
|
2016-03-25 |
2019-01-30 |
Editas Medicine, Inc. |
Systems and methods for treating alpha 1-antitrypsin (a1at) deficiency
|
|
ES3030658T3
(en)
|
2016-03-30 |
2025-07-01 |
Intellia Therapeutics Inc |
Lipid nanoparticle formulations for crispr/cas components
|
|
JP2019103391A
(ja)
|
2016-04-14 |
2019-06-27 |
国立大学法人 東京医科歯科大学 |
単球系統のみに分化するヒト単球前駆細胞およびその単離方法
|
|
EP4166161B1
(en)
|
2016-04-14 |
2026-03-04 |
Fred Hutchinson Cancer Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
KR20260004568A
(ko)
|
2016-04-19 |
2026-01-08 |
더 브로드 인스티튜트, 인코퍼레이티드 |
신규한 crispr 효소 및 시스템
|
|
CA3026110A1
(en)
|
2016-04-19 |
2017-11-02 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
WO2017191503A1
(en)
|
2016-05-05 |
2017-11-09 |
Crispr Therapeutics Ag |
Materials and methods for treatment of hemoglobinopathies
|
|
FR3051555B1
(fr)
|
2016-05-20 |
2018-05-11 |
Horiba Abx Sas |
Detection de la maladie residuelle du myelome multiple
|
|
MX2018014577A
(es)
|
2016-05-27 |
2019-05-20 |
Tg Therapeutics Inc |
Combinacion de anticuerpo anti-cd20, inhibidor selectivo de quinasa p13-delta, e inhibidor de btk para tratar trastornos proliferativos de celulas b.
|
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
|
CN109641051A
(zh)
|
2016-06-17 |
2019-04-16 |
美真达治疗公司 |
用于耗尽细胞的组合物和方法
|
|
US10111966B2
(en)
|
2016-06-17 |
2018-10-30 |
Magenta Therapeutics, Inc. |
Methods for the depletion of CD117+ cells
|
|
WO2018020323A2
(en)
|
2016-07-25 |
2018-02-01 |
Crispr Therapeutics Ag |
Materials and methods for treatment of fatty acid disorders
|
|
WO2018027078A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harard College |
Adenosine nucleobase editors and uses thereof
|
|
US12350349B2
(en)
|
2016-08-03 |
2025-07-08 |
Washington University |
Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptors
|
|
AU2017308889B2
(en)
|
2016-08-09 |
2023-11-09 |
President And Fellows Of Harvard College |
Programmable Cas9-recombinase fusion proteins and uses thereof
|
|
US11352647B2
(en)
|
2016-08-17 |
2022-06-07 |
The Broad Institute, Inc. |
Crispr enzymes and systems
|
|
WO2018039438A1
(en)
*
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
CN110023489A
(zh)
|
2016-08-29 |
2019-07-16 |
Pdi医药发展国际股份公司 |
提供治疗活性细胞产物
|
|
WO2018041973A1
(en)
|
2016-09-01 |
2018-03-08 |
Proqr Therapeutics Ii B.V. |
Chemically modified single-stranded rna-editing oligonucleotides
|
|
US11590098B2
(en)
|
2016-09-06 |
2023-02-28 |
Mayo Foundation For Medical Education And Research |
Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins
|
|
KR20240007715A
(ko)
|
2016-10-14 |
2024-01-16 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵염기 에디터의 aav 전달
|
|
US20190365806A1
(en)
|
2016-11-02 |
2019-12-05 |
Universität Basel |
Immunologically discernible cell surface variants for use in cell therapy
|
|
WO2018085516A2
(en)
|
2016-11-02 |
2018-05-11 |
Aal Scientifics, Inc. |
Non-mesenchymal human lung stem cells and methods of their use for treating respiratory diseases
|
|
US11180778B2
(en)
|
2016-11-11 |
2021-11-23 |
The Regents Of The University Of California |
Variant RNA-guided polypeptides and methods of use
|
|
CN107043779B
(zh)
|
2016-12-01 |
2020-05-12 |
中国农业科学院作物科学研究所 |
一种CRISPR/nCas9介导的定点碱基替换在植物中的应用
|
|
EP3551757A1
(en)
|
2016-12-08 |
2019-10-16 |
Intellia Therapeutics, Inc. |
Modified guide rnas
|
|
JP7383478B2
(ja)
|
2016-12-22 |
2023-11-20 |
インテリア セラピューティクス，インコーポレイテッド |
アルファ１アンチトリプシン欠乏症を治療するための組成物および方法
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
KR102569848B1
(ko)
|
2016-12-23 |
2023-08-25 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
Pcsk9의 유전자 편집
|
|
EP3401834B1
(en)
|
2016-12-26 |
2022-08-17 |
Shenzhen Goodix Technology Co., Ltd. |
Fingerprint recognition system
|
|
EP3565608A4
(en)
|
2017-01-05 |
2020-12-16 |
Rutgers, The State University of New Jersey |
TARGETED GENE EDITING PLATFORM INDEPENDENT OF BICATENARY DNA BREAKAGE AND ITS USES
|
|
SG11201906319XA
(en)
|
2017-01-20 |
2019-08-27 |
Magenta Therapeutics Inc |
Compositions and methods for the depletion of cd137+ cells
|
|
IL301075B2
(en)
|
2017-01-30 |
2024-05-01 |
Univ Leland Stanford Junior |
A genotoxic matching regimen for stem cell transplantation
|
|
TW201839136A
(zh)
|
2017-02-06 |
2018-11-01 |
瑞士商諾華公司 |
治療血色素異常症之組合物及方法
|
|
WO2018152197A1
(en)
|
2017-02-15 |
2018-08-23 |
Massachusetts Institute Of Technology |
Dna writers, molecular recorders and uses thereof
|
|
KR102709603B1
(ko)
|
2017-02-28 |
2024-09-27 |
보르 바이오파마 인크. |
계통 특이적 단백질의 억제를 위한 조성물 및 방법
|
|
CN110914310A
(zh)
|
2017-03-10 |
2020-03-24 |
哈佛大学的校长及成员们 |
胞嘧啶至鸟嘌呤碱基编辑器
|
|
EP3596217A1
(en)
|
2017-03-14 |
2020-01-22 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
IL306092A
(en)
|
2017-03-23 |
2023-11-01 |
Harvard College |
Nucleic base editors that include nucleic acid programmable DNA binding proteins
|
|
US12485186B2
(en)
|
2017-03-31 |
2025-12-02 |
The Children's Medical Center Corporation |
Antibody-mediated conditioning with immunosuppression to enable allogeneic transplantation
|
|
CN106916852B
(zh)
|
2017-04-13 |
2020-12-04 |
上海科技大学 |
一种碱基编辑系统及其构建和应用方法
|
|
PL3609540T3
(pl)
|
2017-04-14 |
2023-03-27 |
Bolt Biotherapeutics, Inc. |
Sposób syntezy immunokoniugatu
|
|
WO2018195545A2
(en)
|
2017-04-21 |
2018-10-25 |
The General Hospital Corporation |
Variants of cpf1 (cas12a) with altered pam specificity
|
|
KR102678809B1
(ko)
|
2017-05-18 |
2024-06-26 |
더 브로드 인스티튜트, 인코퍼레이티드 |
표적화된 핵산 편집을 위한 시스템, 방법 및 조성물
|
|
EP3625342B1
(en)
|
2017-05-18 |
2022-08-24 |
The Broad Institute, Inc. |
Systems, methods, and compositions for targeted nucleic acid editing
|
|
CA3063733A1
(en)
|
2017-05-25 |
2018-11-29 |
The General Hospital Corporation |
Base editors with improved precision and specificity
|
|
IT201700062176A1
(it)
|
2017-06-07 |
2018-12-07 |
Univ Degli Studi Milano |
Metodo per l’isolamento di sottopopolazioni di progenitori cellulari cardiaci e relativi usi in campo medico
|
|
WO2019005886A1
(en)
|
2017-06-26 |
2019-01-03 |
The Broad Institute, Inc. |
CRISPR / CAS-CYTIDINE DEAMINASE COMPOSITIONS, SYSTEMS AND METHODS FOR TARGETED EDITING OF NUCLEIC ACIDS
|
|
CN111328290A
(zh)
|
2017-06-26 |
2020-06-23 |
博德研究所 |
用于靶向核酸编辑的基于crispr/cas-腺嘌呤脱氨酶的组合物、系统和方法
|
|
US10392616B2
(en)
|
2017-06-30 |
2019-08-27 |
Arbor Biotechnologies, Inc. |
CRISPR RNA targeting enzymes and systems and uses thereof
|
|
US20200140896A1
(en)
|
2017-06-30 |
2020-05-07 |
Novartis Ag |
Methods for the treatment of disease with gene editing systems
|
|
CA3070242A1
(en)
|
2017-07-18 |
2019-01-24 |
Calimmune, Inc. |
Compositions and methods for treating beta-hemoglobinopathies
|
|
EP3658589B1
(en)
|
2017-07-26 |
2023-09-27 |
Forty Seven, Inc. |
Anti-sirp-alpha antibodies and related methods
|
|
EP3658573A1
(en)
|
2017-07-28 |
2020-06-03 |
President and Fellows of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
|
|
WO2019040650A1
(en)
|
2017-08-23 |
2019-02-28 |
The General Hospital Corporation |
GENETICALLY MODIFIED CRISPR-CAS9 NUCLEASES HAVING MODIFIED PAM SPECIFICITY
|
|
EP3676376B1
(en)
|
2017-08-30 |
2025-01-15 |
President and Fellows of Harvard College |
High efficiency base editors comprising gam
|
|
US10849924B2
(en)
|
2017-09-26 |
2020-12-01 |
New York Medical College |
Compositions and methods for restoring endothelial glycocalyx
|
|
IL316453A
(en)
|
2017-10-06 |
2024-12-01 |
Univ Oregon Health & Science |
RNA editing agents and methods
|
|
CA3082251A1
(en)
|
2017-10-16 |
2019-04-25 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
|
CN111565719A
(zh)
|
2017-10-17 |
2020-08-21 |
瑞真药业公司 |
用于治疗食管癌的crac通道调节剂
|
|
WO2019084053A1
(en)
|
2017-10-24 |
2019-05-02 |
Magenta Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR DEPLOYING CD117 + CELLS
|
|
EP3700568A4
(en)
|
2017-10-24 |
2021-11-10 |
Magenta Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR DEPLOYING CD117 + CELLS
|
|
US10882915B2
(en)
|
2017-10-24 |
2021-01-05 |
Magenta Therapeutics, Inc. |
Compositions and methods for the depletion of CD117+ cells
|
|
WO2019082124A1
(en)
|
2017-10-26 |
2019-05-02 |
Rhizen Pharmaceuticals Sa |
COMPOSITION AND METHOD FOR THE TREATMENT OF LARGE B-CELL DIFFUSED LYMPHOMA
|
|
MA50849A
(fr)
|
2017-10-26 |
2020-09-02 |
Vertex Pharma |
Substances et procédés pour le traitement d'hémoglobinopathies
|
|
EA202090682A1
(ru)
|
2017-10-30 |
2020-10-15 |
Ризен Фармасьютикалз Са |
Модуляторы кальциевых каналов, активируемых высвобождением кальция, для лечения гематологических и солидных раковых заболеваний
|
|
CN111770776A
(zh)
|
2017-12-06 |
2020-10-13 |
瑞真药业公司 |
治疗外周t细胞淋巴瘤和皮肤t细胞淋巴瘤的组合物和方法
|
|
WO2019113437A1
(en)
|
2017-12-08 |
2019-06-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hematopoietic stem cell engraftment
|
|
AU2018383712B2
(en)
|
2017-12-11 |
2025-09-04 |
Editas Medicine, Inc. |
Cpf1-related methods and compositions for gene editing
|
|
AR114014A1
(es)
|
2017-12-22 |
2020-07-08 |
Inst Genetics & Developmental Biology Cas |
Sistema de edición de bases y método basado en proteína cpf1
|
|
US20230193242A1
(en)
|
2017-12-22 |
2023-06-22 |
The Broad Institute, Inc. |
Cas12b systems, methods, and compositions for targeted dna base editing
|
|
GB201802201D0
(en)
|
2018-02-09 |
2018-03-28 |
Ultrahuman Five Ltd |
Binding agents
|
|
CA3093289A1
(en)
|
2018-03-07 |
2019-09-12 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
WO2019178280A1
(en)
|
2018-03-13 |
2019-09-19 |
Amgen Inc. |
Sequential digestion of polypeptides for mass spectrometric analysis
|
|
WO2019178151A1
(en)
|
2018-03-13 |
2019-09-19 |
Amgen Inc. |
Methods for the preparation of trypsin-resistant polypeptides for mass spectrometric analysis
|
|
IL277234B2
(en)
|
2018-03-14 |
2026-03-01 |
Editas Medicine Inc |
Systems and methods for treating hemoglobin diseases
|
|
EP3765617A1
(en)
|
2018-03-14 |
2021-01-20 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
US20210363518A1
(en)
|
2018-03-19 |
2021-11-25 |
University Of Massachusetts |
Modified guide rnas for crispr genome editing
|
|
AU2019256287B2
(en)
|
2018-04-17 |
2026-02-05 |
The General Hospital Corporation |
Sensitive in vitro assays for substrate preferences and sites of nucleic acid binding, modifying, and cleaving agents
|
|
WO2019217942A1
(en)
|
2018-05-11 |
2019-11-14 |
Beam Therapeutics Inc. |
Methods of substituting pathogenic amino acids using programmable base editor systems
|
|
KR102959497B1
(ko)
|
2018-05-11 |
2026-05-04 |
빔 테라퓨틱스, 인크. |
프로그래밍가능한 염기 편집기 시스템을 이용하여 병원성 돌연변이를 억제하는 방법
|
|
KR102853088B1
(ko)
|
2018-05-11 |
2025-09-02 |
빔 테라퓨틱스, 인크. |
프로그래밍가능한 염기 편집기 시스템을 이용하여 단일염기다형성을 편집하는 방법
|
|
JP7577648B2
(ja)
|
2018-05-14 |
2024-11-05 |
センバ インコーポレイテッド |
自己免疫疾患のための遺伝子編集
|
|
WO2019226953A1
(en)
|
2018-05-23 |
2019-11-28 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
JP2021526525A
(ja)
|
2018-06-07 |
2021-10-07 |
マジェンタ セラピューティクス インコーポレイテッドＭａｇｅｎｔａ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
抗体薬物コンジュゲート（ａｄｃｓ）を用いた治療方法
|
|
KR102894715B1
(ko)
|
2018-08-03 |
2025-12-03 |
빔 테라퓨틱스, 인크. |
핵산 표적 서열을 변형시키기 위한 다중-이펙터 핵염기 편집기 및 이를 이용하는 방법
|
|
WO2020041751A1
(en)
|
2018-08-23 |
2020-02-27 |
The Broad Institute, Inc. |
Cas9 variants having non-canonical pam specificities and uses thereof
|
|
JP2021534769A
(ja)
|
2018-08-31 |
2021-12-16 |
エーエルエックス オンコロジー インコーポレイテッド |
デコイポリペプチド
|
|
KR20210055733A
(ko)
|
2018-09-07 |
2021-05-17 |
빔 테라퓨틱스, 인크. |
핵염기 편집 시스템을 전달하기 위한 조성물 및 방법
|
|
GB201815670D0
(en)
|
2018-09-26 |
2018-11-07 |
Univ Oxford Innovation Ltd |
Protein editing
|
|
CN109295186B
(zh)
|
2018-09-30 |
2023-10-03 |
中山大学 |
一种基于全基因组测序检测腺嘌呤单碱基编辑系统脱靶效应的方法及其在基因编辑中的应用
|
|
CN113302493A
(zh)
|
2018-10-01 |
2021-08-24 |
小利兰·斯坦福大学托管委员会 |
同时解析多种抗体同种型的高特异性和灵敏度免疫吸附诊断测定
|
|
KR102716514B1
(ko)
|
2018-10-10 |
2024-10-15 |
주식회사 노벨티노빌리티 |
신규 항-c-KIT 항체
|
|
US20200376135A1
(en)
|
2018-10-23 |
2020-12-03 |
Magenta Therapeutics, Inc. |
Fc silenced antibody drug conjugates (adcs) and uses thereof
|
|
CN113330026A
(zh)
|
2018-10-23 |
2021-08-31 |
美真达治疗公司 |
Fc沉默的抗体药物缀合物(ADC)及其用途
|
|
AU2019374055B2
(en)
|
2018-10-30 |
2026-06-11 |
Regeneron Pharmaceuticals, Inc. |
Methods for allogeneic hematopoietic stem cell transplantation
|
|
UA128431C2
(uk)
|
2018-11-26 |
2024-07-10 |
Форті Севен, Інк. |
ГУМАНІЗОВАНЕ АНТИТІЛО ДО c-Kit
|
|
KR20210094609A
(ko)
|
2018-11-28 |
2021-07-29 |
포티 세븐, 인코포레이티드 |
절제 레짐에 대해 저항성인 유전적으로 변형된 hspc
|
|
EP3887521A1
(en)
|
2018-11-29 |
2021-10-06 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
US12000775B2
(en)
|
2018-12-14 |
2024-06-04 |
Amgen Inc. |
System suitability method for use with protein concentration determination by slope
|
|
AU2020216484A1
(en)
|
2019-01-31 |
2021-07-29 |
Beam Therapeutics Inc. |
Nucleobase editors having reduced off-target deamination and methods of using same to modify a nucleobase target sequence
|
|
JP7646552B2
(ja)
|
2019-01-31 |
2025-03-17 |
ビーム セラピューティクス インク． |
低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ
|
|
WO2020163396A1
(en)
|
2019-02-04 |
2020-08-13 |
The General Hospital Corporation |
Adenine dna base editor variants with reduced off-target rna editing
|
|
EP3924479A4
(en)
|
2019-02-13 |
2023-01-25 |
Beam Therapeutics, Inc. |
ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING THEM TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE
|
|
CN114096666B
(zh)
|
2019-02-13 |
2025-03-18 |
比姆医疗股份有限公司 |
治疗血红素病变的组合物和方法
|
|
US20220127594A1
(en)
|
2019-02-13 |
2022-04-28 |
Beam Therapeutics Inc. |
Compositions and methods for treating glycogen storage disease type 1a
|
|
US12600971B2
(en)
|
2019-02-13 |
2026-04-14 |
Beam Therapeutics Inc. |
Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence
|
|
WO2020168135A1
(en)
|
2019-02-13 |
2020-08-20 |
Beam Therapeutics Inc. |
Compositions and methods for treating alpha-1 antitrypsin deficiency
|
|
US20220098593A1
(en)
|
2019-02-13 |
2022-03-31 |
Beam Therapeutics Inc. |
Splice acceptor site disruption of a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic disease
|
|
CN114040970B
(zh)
|
2019-02-13 |
2024-09-27 |
比姆医疗股份有限公司 |
使用腺苷脱氨酶碱基编辑器编辑疾病相关基因的方法，包括遗传性疾病的治疗
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
CA3134319A1
(en)
|
2019-04-24 |
2020-10-29 |
Rahul Palchaudhuri |
Anti-cd117 antibodies and uses thereof
|
|
WO2020216947A1
(en)
|
2019-04-24 |
2020-10-29 |
Heidelberg Pharma Research Gmbh |
Amatoxin antibody-drug conjugates and uses thereof
|
|
WO2020219778A2
(en)
|
2019-04-24 |
2020-10-29 |
Magenta Therapeutics, Inc. |
Anti-cd117 antibody-drug conjugates and uses thereof
|
|
JP2022530442A
(ja)
|
2019-04-24 |
2022-06-29 |
マジェンタ セラピューティクス インコーポレイテッド |
アントラサイクリン抗体薬物複合体およびその使用
|
|
JP2022529727A
(ja)
|
2019-04-24 |
2022-06-23 |
マジェンタ セラピューティクス インコーポレイテッド |
Ａｎｔｉ－ｃｄ１１７ とその使用
|
|
JP2022530438A
(ja)
|
2019-04-24 |
2022-06-29 |
マジェンタ セラピューティクス インコーポレイテッド |
抗ｃｄ１１７抗体薬物複合体およびその使用
|
|
EP3958878A4
(en)
|
2019-04-24 |
2022-12-28 |
Magenta Therapeutics, Inc. |
CONDITIONING METHODS FOR GENE THERAPY
|
|
EP3958879A4
(en)
|
2019-04-25 |
2023-05-10 |
Actinium Pharmaceuticals, Inc. |
Compositions and methods of immunodepletion for the treatment of malignant and non-malignant hematological diseases
|
|
CN110042124A
(zh)
|
2019-04-25 |
2019-07-23 |
国家卫生健康委科学技术研究所 |
基因组碱基编辑增加人红细胞中胎儿血红蛋白水平的试剂盒及应用
|
|
JP7679311B2
(ja)
|
2019-05-21 |
2025-05-19 |
ビーム セラピューティクス インク． |
プログラム可能塩基エディターシステムを用いた一塩基多型編集法
|
|
KR20220012328A
(ko)
|
2019-05-24 |
2022-02-03 |
포티 세븐, 인코포레이티드 |
c-kit 및 CD47에 대한 면역요법제의 병용 투여를 위한 요법
|
|
EP3983405A4
(en)
|
2019-06-12 |
2023-06-07 |
Ontario Institute for Cancer Research (OICR) |
NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) INHIBITING CONJUGATES AND USES THEREOF
|
|
KR102258713B1
(ko)
|
2019-07-31 |
2021-05-31 |
한양대학교 산학협력단 |
사이토신 염기교정용 조성물 및 이의 용도
|
|
US20220288118A1
(en)
|
2019-07-31 |
2022-09-15 |
Forty Seven, Inc. |
Depletion regimes for engineered t-cell or nk-cell therapy
|
|
AU2020336969B2
(en)
|
2019-08-29 |
2024-12-05 |
Beam Therapeutics Inc. |
Compositions and methods for non-toxic conditioning
|
|
GB201912681D0
(en)
|
2019-09-04 |
2019-10-16 |
Eth Zuerich |
Bispecific binding agent that binds to cd117/c-kit and cd3
|
|
AU2020344547A1
(en)
|
2019-09-09 |
2022-03-24 |
Beam Therapeutics Inc. |
Novel nucleobase editors and methods of using same
|
|
ES2960527T3
(es)
|
2019-09-13 |
2024-03-05 |
Miltenyi Biotec Bv & Co Kg |
Método para la generación de una composición celular de células progenitoras dopaminérgicas del mesencéfalo ventral
|
|
US20220324957A1
(en)
|
2019-09-16 |
2022-10-13 |
Opsidio, LLC |
Anti-stem cell factor antibodies and methods of use thereof in renal disease
|
|
AU2020466994B2
(en)
|
2019-09-17 |
2026-05-28 |
Rutgers, The State University Of New Jersey |
Highly efficient DNA base editors mediated by RNA-aptamer recruitment for targeted genome modification and uses thereof
|
|
CN112125915A
(zh)
|
2019-09-18 |
2020-12-25 |
四川百利药业有限责任公司 |
一种喜树碱衍生物及其偶联物
|
|
US20220380757A1
(en)
|
2019-09-30 |
2022-12-01 |
The Children's Medical Center Corporation |
Bcl11a guide and base editor delivery
|
|
CN114828842A
(zh)
|
2019-10-21 |
2022-07-29 |
理森制药股份公司 |
用于治疗急性髓系白血病的包含dhodh抑制剂的组合物
|
|
NL2024163B1
(en)
|
2019-11-05 |
2021-07-20 |
Univ Of Salamanca |
Means and methods for multiparameter cytometry-based leukocyte subsetting.
|
|
AU2020383622A1
(en)
|
2019-11-15 |
2022-06-16 |
Secretome Therapeutics, Inc. |
Immortalized cardiac stem cells for cardiac repair
|
|
EP3825330A1
(en)
|
2019-11-19 |
2021-05-26 |
International-Drug-Development-Biotech |
Anti-cd117 antibodies and methods of use thereof
|
|
KR102772859B1
(ko)
|
2019-11-25 |
2025-02-27 |
주식회사 노벨티노빌리티 |
c-kit에 대한 항체 및 이의 용도
|
|
WO2021123397A1
(en)
|
2019-12-20 |
2021-06-24 |
Biogemma |
IMPROVING EFFICIENCY OF BASE EDITING USING TypeV CRISPR ENZYMES
|
|
US20230235309A1
(en)
|
2020-02-05 |
2023-07-27 |
The Broad Institute, Inc. |
Adenine base editors and uses thereof
|
|
WO2021158999A1
(en)
|
2020-02-05 |
2021-08-12 |
The Broad Institute, Inc. |
Gene editing methods for treating spinal muscular atrophy
|
|
CN116113692A
(zh)
|
2020-02-13 |
2023-05-12 |
比姆医疗股份有限公司 |
用于植入碱基编辑细胞的组合物和方法
|
|
BR112022017732A2
(pt)
|
2020-03-04 |
2023-01-17 |
Suzhou Qi Biodesign Biotechnology Company Ltd |
Sistema aperfeiçoado de edição de base de citosina
|
|
GB202003129D0
(en)
|
2020-03-04 |
2020-04-15 |
Hansa Biopharma AB |
Conditioning regimen for transplant of stem cells
|
|
EP4121462A4
(en)
|
2020-03-16 |
2024-04-24 |
Magenta Therapeutics, Inc. |
BISPECIFIC T CELL BINDING PROTEINS
|
|
WO2021188840A1
(en)
|
2020-03-19 |
2021-09-23 |
Rewrite Therapeutics, Inc. |
Methods and compositions for directed genome editing
|
|
EP4132951A4
(en)
|
2020-04-09 |
2025-06-11 |
Verve Therapeutics, Inc. |
CHEMICALLY MODIFIED GENE EDITING GUIDE RNAS WITH CAS12B
|
|
US20230121577A1
(en)
|
2020-04-15 |
2023-04-20 |
The Regents Of The University Of California |
Compositions and Methods for Treatment
|
|
US20230279438A1
(en)
|
2020-05-13 |
2023-09-07 |
Inserm (Institut National De La Santé Et La Recherche Médicale) |
Base editing approaches for the treatment of betahemoglobinopathies
|
|
JP7820823B2
(ja)
|
2020-05-27 |
2026-02-26 |
ウニヴェルジテート・チューリッヒ |
骨髄性細胞およびミクログリアにおいて特異的に治療タンパク質を発現するウイルスベクター
|
|
BR112022024930A2
(pt)
|
2020-06-08 |
2022-12-27 |
Baili Bio Chengdu Pharmaceutical Co Ltd |
Fármaco de camptotecina possuindo unidade de conexão hidrofílica de alta estabilidade e conjugado do mesmo
|
|
EP4179079A1
(en)
|
2020-07-10 |
2023-05-17 |
Horizon Discovery Limited |
Method for producing genetically modified cells
|
|
WO2022011458A1
(en)
|
2020-07-13 |
2022-01-20 |
Ontario Institute For Cancer Research (Oicr) |
Nicotinamide phosphoribosyltransferase (nampt) inhibitor-conjugates and uses thereof
|
|
JP7890972B2
(ja)
|
2020-07-15 |
2026-07-15 |
ライフ エディット セラピューティクス，インコーポレイティド |
ウラシル安定化タンパク質並びにその活性断片及びバリアント並びに使用方法
|
|
WO2022036179A2
(en)
|
2020-08-14 |
2022-02-17 |
Orchard Therapeutics (Europe) Limited |
Compositions and methods for treating or preventing hereditary angioedema
|
|
WO2022040596A1
(en)
|
2020-08-20 |
2022-02-24 |
Ambrx, Inc. |
Antibody-tlr agonist conjugates, methods and uses thereof
|
|
MX2023002318A
(es)
|
2020-08-29 |
2023-05-19 |
argenx BV |
Metodo de tratamiento de pacientes con sensibilidad reducida a un inhibidor de bcl-2.
|
|
EP4211235A2
(en)
|
2020-09-11 |
2023-07-19 |
Lifeedit Therapeutics, Inc. |
Dna modifying enzymes and active fragments and variants thereof and methods of use
|
|
CA3192224A1
(en)
|
2020-09-11 |
2022-03-17 |
Jyun-Liang LIN |
Base editing enzymes
|
|
US20230383277A1
(en)
|
2020-10-14 |
2023-11-30 |
Beam Therapeutics Inc. |
Compositions and methods for treating glycogen storage disease type 1a
|
|
WO2022081828A1
(en)
|
2020-10-16 |
2022-04-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hematopoietic stem cell engraftment with a combination of agents
|
|
IT202000028688A1
(it)
|
2020-11-27 |
2022-05-27 |
Consiglio Nazionale Ricerche |
Varianti della citidina deaminasi per l’editazione di basi
|
|
WO2022143694A1
(zh)
|
2020-12-28 |
2022-07-07 |
华东师范大学 |
一种针对细胞中单个或多个基因进行基因编辑的方法、产品和应用
|
|
WO2022150706A2
(en)
|
2021-01-08 |
2022-07-14 |
The General Hospital Corporation |
Genome editing approaches to treat spinal muscular atrophy
|
|
US20240360414A1
(en)
|
2021-01-15 |
2024-10-31 |
St. Jude Children's Research Hospital, Inc. |
Systems and Methods for Base Editing Of HBG1/2 Gene Promoter and Fetal Hemoglobin Induction
|
|
WO2023279118A2
(en)
|
2021-07-02 |
2023-01-05 |
University Of Maryland, College Park |
Cytidine deaminases and methods of genome editing using the same
|
|
EP4396207A4
(en)
|
2021-09-03 |
2025-07-16 |
Univ Chicago |
POLYPEPTIDES AND METHODS FOR MODIFYING NUCLEIC ACIDS
|
|
GB2702733A
(en)
|
2021-09-22 |
2026-06-24 |
Verve Therapeutics Inc |
Gene editing of PCSK9 or ANGPTL3 and compositions and methods of using same for treatment of disease
|
|
US20230105319A1
(en)
|
2021-09-24 |
2023-04-06 |
Crispr Therapeutics Ag |
PRODRUG INCORPORATED sgRNA SYNTHESIS
|
|
WO2023125814A1
(zh)
|
2021-12-29 |
2023-07-06 |
华东师范大学 |
腺嘌呤脱氨酶及其应用
|
|
WO2023155901A1
(en)
|
2022-02-17 |
2023-08-24 |
Correctsequence Therapeutics |
Mutant cytidine deaminases with improved editing precision
|
|
EP4540378A1
(en)
|
2022-06-20 |
2025-04-23 |
CRISPR Therapeutics AG |
Base editing proteins and uses thereof
|
|
JP2025520697A
(ja)
|
2022-06-23 |
2025-07-03 |
ビーエーエスエフ アグリカルチュラル ソリューションズ ユーエス エルエルシー |
多様化塩基編集
|